Common Contracts
45 similar null contracts by Peregrine Pharmaceuticals Inc, GreenHunter Resources, Inc., Acelrx Pharmaceuticals Inc, others
GERON CORPORATION Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementGeron Corp • August 28th, 2015 • Pharmaceutical preparations • New York
Geron Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
At Market Issuance Sales AgreementPeregrine Pharmaceuticals Inc • August 7th, 2015 • Pharmaceutical preparations • Colorado
GASTAR EXPLORATION INC. Common Stock (par value $0.001 per share)Gastar Exploration Inc. • May 7th, 2015 • Crude petroleum & natural gas • New York
Gastar Exploration Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
Common Stock and Series D Preferred Stock) April , 2015Shale Hunter, LLC • April 15th, 2015 • Crude petroleum & natural gas • New York
Magnum Hunter Resources Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
At Market Issuance Sales AgreementAsterias Biotherapeutics, Inc. • April 10th, 2015 • Biological products, (no disgnostic substances) • New York
Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At-the-Market Issuance Sales AgreementOramed Pharmaceuticals Inc. • April 3rd, 2015 • Pharmaceutical preparations • New York
Oramed Pharmaceuticals Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
REXAHN PHARMACEUTICALS, INC.Rexahn Pharmaceuticals, Inc. • March 16th, 2015 • Pharmaceutical preparations • New York
Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
ANWORTH MORTGAGE ASSET CORPORATION Common Stock (par value $0.01 per share) (par value $0.01 per share) (par value $0.01 per share) AT MARKET ISSUANCE SALES AGREEMENTAnworth Mortgage Asset Corp • March 6th, 2015 • Real estate investment trusts • New York
ANWORTH MORTGAGE ASSET CORPORATION, a Maryland corporation (the “Company”), and ANWORTH MANAGEMENT LLC, a Delaware limited liability company (the “Manager”), confirm their agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
At-The-Market Issuance Sales AgreementPostRock Energy Corp • February 10th, 2015 • Crude petroleum & natural gas • New York
PostRock Energy Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
ROCK CREEK PHARMACEUTICALS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementRock Creek Pharmaceuticals, Inc. • December 15th, 2014 • Medicinal chemicals & botanical products • New York
Rock Creek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
GREENHUNTER RESOURCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementGreenHunter Resources, Inc. • October 31st, 2014 • Industrial organic chemicals • New York
GREENHUNTER RESOURCES, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
GLOWPOINT, INC.Glowpoint, Inc. • September 16th, 2014 • Telephone communications (no radiotelephone) • New York
GREENHUNTER RESOURCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementGreenHunter Resources, Inc. • August 11th, 2014 • Industrial organic chemicals • New York
GREENHUNTER RESOURCES, INC., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
At Market Issuance Sales AgreementThreshold Pharmaceuticals Inc • August 1st, 2014 • Pharmaceutical preparations • New York
Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
At Market Issuance Sales AgreementPeregrine Pharmaceuticals Inc • June 16th, 2014 • Pharmaceutical preparations • Colorado
Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
At Market Issuance Sales AgreementPeregrine Pharmaceuticals Inc • June 16th, 2014 • Pharmaceutical preparations • Colorado
Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
RAIT FINANCIAL TRUST UP TO $150,000,000 Up to 4,000,000 7.75% Series A Cumulative Redeemable Preferred Shares Up to 1,000,000 8.375% Series B Cumulative Redeemable Preferred Shares Up to 1,000,000 8.875% Series C Cumulative Redeemable Preferred Shares...RAIT Financial Trust • June 13th, 2014 • Real estate investment trusts • New York
RAIT Financial Trust, a Maryland real estate investment trust (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
ZAZA ENERGY CORPORATION Common Stock (par value $0.01 per share) At-the-Market Issuance Sales AgreementZaZa Energy Corp • March 31st, 2014 • Crude petroleum & natural gas • New York
ZaZa Energy Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At Market Issuance Sales AgreementCardiome Pharma Corp • February 18th, 2014 • Pharmaceutical preparations • New York
Cardiome Pharma Corp. (the “Company”), a corporation formed under the Canada Business Corporations Act (the “CBCA”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
AMERICAN SUPERCONDUCTOR CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAmerican Superconductor Corp /De/ • November 18th, 2013 • Motors & generators • New York
American Superconductor Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
At the Market Issuance Sales AgreementLigand Pharmaceuticals Inc • October 16th, 2013 • Pharmaceutical preparations • New York
Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
CORONADO BIOSCIENCES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementCoronado Biosciences Inc • April 29th, 2013 • Pharmaceutical preparations • New York
Coronado Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
At Market Issuance Sales AgreementPeregrine Pharmaceuticals Inc • December 28th, 2012 • Pharmaceutical preparations • Colorado
Peregrine Pharmaceuticals, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with ”)MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
ANTHERA PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAnthera Pharmaceuticals Inc • November 8th, 2012 • Pharmaceutical preparations • New York
Anthera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
At Market Issuance Sales AgreementNovavax Inc • October 2nd, 2012 • Biological products, (no disgnostic substances) • New York
Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
ACELRX PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAcelrx Pharmaceuticals Inc • August 31st, 2012 • Pharmaceutical preparations • New York
AcelRx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
FIELDPOINT PETROLEUM CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementFieldpoint Petroleum Corp • May 17th, 2012 • Crude petroleum & natural gas • New York
ECHO THERAPEUTICS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementEcho Therapeutics, Inc. • May 10th, 2012 • Electromedical & electrotherapeutic apparatus • New York
Echo Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
COMPLETE GENOMICS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementComplete Genomics Inc • March 12th, 2012 • Services-commercial physical & biological research • New York
Complete Genomics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “MLV”), as follows:
WAVE SYSTEMS CORP. Class A Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementWave Systems Corp • January 30th, 2012 • Computer peripheral equipment, nec • New York
Wave Systems Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementUs Geothermal Inc • September 30th, 2011 • Electric services • New York
MIDWAY GOLD CORP. Common Shares At Market Issuance Sales AgreementMidway Gold Corp • September 26th, 2011 • Gold and silver ores • New York
Midway Gold Corp., a corporation organized and existing under the laws of British Columbia (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (the “MLV”), as follows:
BEACON POWER CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementBeacon Power Corp • August 24th, 2011 • Electric services • New York
Beacon Power Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows:
ContractCardica Inc • August 4th, 2011 • Surgical & medical instruments & apparatus • New York
EVOLUTION PETROLEUM CORPORATION Series A Cumulative Preferred Stock (par value $0.001 per share) At-The-Market Issuance Sales AgreementEvolution Petroleum Corp • July 15th, 2011 • Crude petroleum & natural gas • New York
Evolution Petroleum Corporation, a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows:
